Bolt Biotherapeutics (BOLT) Change in Acquisitions & Divestments (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Change in Acquisitions & Divestments for 6 consecutive years, with $12.9 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments fell 49.33% to $12.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $72.4 million through Dec 2025, down 50.5% year-over-year, with the annual reading at $72.4 million for FY2025, 50.5% down from the prior year.
  • Change in Acquisitions & Divestments hit $12.9 million in Q4 2025 for Bolt Biotherapeutics, down from $19.7 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $117.5 million in Q1 2022 to a low of $3.8 million in Q2 2021.
  • Historically, Change in Acquisitions & Divestments has averaged $39.0 million across 5 years, with a median of $35.3 million in 2024.
  • Biggest five-year swings in Change in Acquisitions & Divestments: soared 1870.87% in 2021 and later plummeted 56.16% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $51.3 million in 2021, then fell by 18.14% to $42.0 million in 2022, then increased by 14.29% to $48.0 million in 2023, then crashed by 46.88% to $25.5 million in 2024, then crashed by 49.33% to $12.9 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for BOLT at $12.9 million in Q4 2025, $19.7 million in Q3 2025, and $25.3 million in Q2 2025.